Dublin, Ireland – May 05, 2021:
Deep search capabilities and extensive integration options amongst suite of enhancements for life science-specific artwork management system GLAMS 5
Perigord announces the release of GLAMS 5.0, the latest update to its industry-leading AMS platform. Developed to the specific needs of the Life Science industry, this latest release boasts an expanded suite of both new and improved features, as well as greatly improved performance.
Perigord Data’s Chief Operations Officer, Suzanne Ivory explained, “GLAMS 5’s new deep search capabilities break down potential impediments to getting products to market, and allows users to create deep and wide-ranging searches of all their artwork data, including querying active text on any uploaded PDFs, making it possible to gather a huge amount of rich, context-filled information quickly, easily, and efficiently.”
With its history of innovation and close cooperation with some of the world’s biggest pharmaceutical companies, Perigord’s development team has added several new features to GLAMS to greatly increase the usability and productivity of the platform for its users. These include:
“Listening to our customers and leveraging our own experience, we have spent several months refining the GLAMS platform,” explained Paul Leamy, Group CTO and Head of Product Innovation at Perigord Data.
“We have added new functionality and increased the processing speed across our product suite. Not only do the new features offer our clients a more holistic experience when managing their artwork, GLAMS 5.0 will greatly improve the speed, usability, scalability, and efficiency of the artwork and labelling process across all phases of the packaging and labelling supply chain for our clients.”
GLAMS is the only artwork management system built specifically for the exacting requirements of the Life Science industry and the release of GLAMS 5 is a further step toward cementing Perigord’s reputation as the go-to AMS solution provider in the sector.
“It is Perigord’s extensive expertise and experience that enables us to develop solutions that streamline the approval process and other aspects of artwork and labelling workflows, essentially removing the bottlenecks that delay the packaging development process,” commented Perigord Data’s Director of Client Services, Sam Cole.
Introducing GLAMS 5’s new features:
“With the new functionality and system improvements included in GLAMS 5.0, I am confident that GLAMS is the best Life Science artwork management system on the market,” said Perigord Data’s COO, Suzanne Ivory.
“The improvements incorporated into GLAMS 5.0 represent not only the cutting edge of AMS technology, but also its continuing evolution toward fulfilling our overall vision of providing a holistic, end-to-end content management solution that provides for all labelling requirements on a regulatory, marketing or packaging level.”
“Working with our product development team, I look forward not only to expanding and improving on the existing performance of the system, but also to introducing new and innovative functionality that will allow our clients take advantage of the technological revolution taking place in content management,” Mrs Ivory concluded.
About GLAMS
For Life Science organisations, managing artwork packaging and marcom workflows is complex, time consuming and prone to error. With labelling and artwork playing such a critical role in the regulatory mandated communication of medicinal formulation, usage instruction, safety and efficacy data and patient information, mistakes can happen! Involving thousands of people across multiple locations, keeping track of all artwork and labelling tasks, approvals and project timelines is a very challenging and costly exercise. Mistakes cause severe delays in product market launches, full product recalls and, in the worst cases, adverse patient reactions.
To mitigate these risks, it is imperative that Life Science organisations have a fully validated and auditable artwork management system in place – a system that simplifies the packaging artwork labelling and regulatory processes and improves productivity.
Designed and developed specifically for the Life Science industry
Perigord’s GLAMS solution has one key differentiator from its AMS competitors – GLAMS is exclusively designed and developed for the Life Science industry. This means that every aspect of the solution, from the base architecture to each function, has a context that resonates with our Life Science partners. This makes the solution footprint more compact, simpler to understand, faster to validate and quicker to implement when compared with generic non-Life Science AMS solutions. Implementing GLAMS will have an immediate positive impact on your business, with measurable benefits far outweighing the cost of ownership.
GLAMS is the only Artwork Management System dedicated to the sector and specifically designed to help reduce risk, speed up artwork turnaround times, remove duplication of effort, and deliver greater business value.
Available from May 2021 onwards – for further insights and technical information, as well as learning new ways to boost business productivity, efficiency, and profitability:
Request a demo at: https://www.glams.com/sign-up/request-demo/
For more information contact your GLAMS Account Manager or:
Mark Ennis
Global Business Development Director
mark.ennis@perigord-as.com
Steven Gaffney
Business Development Executive
steven.gaffney@perigord-as.com
Perigord Life Science Solutions
Unit 1, Lyncon Court IDA Business & Technology Park
Snugborough Road, Blanchardstown
Dublin, D15 N283, Ireland
mediarelations@perigord-as.com
Tel: +353 1 440 3222
admin
Perigord releases most powerful GLAMS yet – GLAMS 5.0 Dublin, Ireland – May 05, 2021: Deep search capabilities and extensive integration options amongst suite of enhancements for life science-specific artwork management system GLAMS 5 Perigord announces the release of GLAMS 5.0, the latest update to its industry-leading AMS platform....
admin
Tech Mahindra Acquires Majority Stake in Perigord Life Science Solutions Tech Mahindra acquires 70% equity stake to augment domain expertise in the global Pharmaceutical, Healthcare and Life Science sectors Dublin – March 15th, 2021: Perigord are happy to announce that Tech Mahindra, a leading provider of digital transformation, consulting,...